Live Breaking News & Updates on Microbion Corp|Page 1

Stay updated with breaking news from Microbion corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Microbion to Present Design of Ongoing Phase 2 Study Treating Diabetic Foot Ulcer Infections at the 2023 Military Health System Research Symposium

Microbion Corporation today announced that the company will be presenting a poster that highlights key clinical study design elements from an ongoing phase 2 study assessing safety and efficacy of topical pravibismane in subjects suffering from moderate infections associated with chronic diabetic foot ulcers at the 2023 Military Health System Research Symposium being held from August 14th to 17th, 2023, at the Gaylord Palms Resort and Convention Center in Kissimmee, FL. This Phase 2 study is fun ....

Brett Baker , Microbion Corp , Microbion Corporation , Cystic Fibrosis Foundation , Chief Innovation Officer , Antimicrobial Countermeasures , Wound Infections , Military Personnel , Florida Exhibit Halla D , Orphan Drug , Fast Track , Naval Medical Research Center , Diabetic Foot Ulcers , Naval Advanced Medical Development , Diabetic Foot Infection , Aylord Palms Resort And Convention Center , Microbion Corporation , Poster Presentation , Phase 2 Study , Clinical Study Design , Brett Baker ,

Microbion to Present New Data Demonstrating that Pravibismane Disrupts Bacterial Bioenergetics at ASM Microbe 2023

/PRNewswire/ - Microbion Corporation today announced that the company has been selected to present a poster highlighting the results from an E. coli CRISPR/Cas. ....

United States , Fenali Parekh , Jeff Millard , Microbion Corporation , Microbion Corp , Cystic Fibrosis Foundation , Pravibismane Impacts Bacterial Bioenergetics , Fatty Acid Biosynthesis , Board Location , Exhibit Poster Hall , Antimicrobial Agents , New Small , Non Beta Lactamase Inhibitors , Chief Scientific Officer , Orphan Drug , Fast Track ,

Microbion Corp. Presents a Poster on Pravibismane's Activity Against Diabetic Foot Infection Patient Isolates

/PRNewswire/ - Microbion Corporation today announced that the company presented a poster focusing on pravibismane s activity against diabetic foot ulcer. ....

Jeff Millard , Microbion Corp , Cystic Fibrosis Foundation , Microbion Corporation , Investigational Health Management Associates , Clinical Laboratory Standards Institute , International Symposium , Diabetic Foot , Potent Activity , Laboratory Standards Institute , Fast Track , Orphan Drug ,